News

Published on

February 10, 2022

Positive UK MHRA Meeting as CYB003 Heads to P1/2a

Companies Mentioned

Cybin Inc.

Click for profile

People Mentioned

Share This Article

‍

Get the Headlines & Market Updates

Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.

Home News Companies Spotlights Subscribe

©2025 Psychedelic Finance. All rights reserved.

Core One Labs Inc.

Enveric Biosciences

Field Trip Health

Filament Health

Mydecine Innovations Group

NeonMind Biosciences Inc.

PsyBio Therapeutics

Psyched Wellness

Pure Extracts Corp

The Good Shroom Co

Tryp Therapeutics

Algernon Pharmaceuticals

Beckley Foundation

BetterLife Pharma

Bexson Biomedical

Braxia Scientific Corp.

CB Therapeutics

Ceruvia Lifesciences

Clairvoyant Therapeutics

Clearmind Medicine

Clexio Biosciences

Cognetivity Neurosciences

Delix Therapeutics

Diamond Therapeutics

Freedom to Operate

HMNC Brain Health

Horizons ETFs Management Inc.

Incannex Healthcare

Ixtlan Bioscience

Johns Hopkins Medicine

MYND Diagnostics

Mind Medicine (MindMed)

MindBio Therapeutics

Mycotopia Therapies

Mycrodose Therapeutics

Neural Therapeutics

Nirvana Life Sciences

Nova Mentis Life Science

Origin Therapeutics

Pasithea Therapeutics

Pharmala Biotech Holdings

Psilotec Health Solutions

Quantified Citizen

Reunion Neuroscience

Revitalist Lifestyle and Wellness

Revive Therapeutics

Seelos Therapeutics

Telescope Innovations

Universal Ibogaine

Wellbeing Digital Sciences

Woke Pharmaceuticals

ATAI Life Sciences

Awakn Life Sciences

Beckley Psytech

Compass Pathways

Doseology Sciences

Entheon Biomedical

Gilgamesh Pharmaceuticals

GoodCap Wellness